Emergent BioSolutions Inc (FRA:ER4)
€ 6.54 +0.14 (+2.19%) Market Cap: 337.36 Mil Enterprise Value: 695.76 Mil PE Ratio: 0 PB Ratio: 0.75 GF Score: 61/100

Emergent BioSolutions Inc at Goldman Sachs Healthcare Conference Transcript

Jun 8, 2026 / 06:00 PM GMT
Release Date Price: €6.94 (-3.48%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EBS.N - Emergent BioSolutions Inc
Emergent BioSolutions Inc at Goldman Sachs Healthcare Conference
Jun 08, 2026 / 06:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative [1]
--------------------------------------------------------------------------------
Good afternoon, everyone. Welcome to the Emergent presentation. Emergent is a very unique healthcare company, a unique business model. We partner with governments around the world on biodefense, which is an important area, especially in this increasingly dangerous world we live in. We make products for some of the most difficult product areas that have significant barriers to entry.

For example, we make a vaccine for smallpox. Once again, one of the number one biodefense or bioterrorist threats. We also make a product for anthrax the number one bacterial problem or bioterrorist threat. And we also make a product, the most lethal toxin out there, [botulism], which is also
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot